Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Artivion Inc. (AORT:NYSE), powered by AI.
Artivion Inc. is currently trading at $25.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Artivion Inc. on Alpha Lenz.
View Artivion Inc.'s valuation metrics on Alpha Lenz.
“Artivion Inc.'s ROE is 2.7%. Explore profitability and growth together.”
Ask for details →Artivion Inc. is a medical device company focused on providing innovative technology solutions aimed at improving patient outcomes. Its primary function is to develop, manufacture, and sell devices associated with cardiac and vascular surgery, with a particular emphasis on cryopreservation and heart valve structures. The company's product portfolio serves critical areas such as aortic repair, heart valve therapy, and advanced cryogenic preservation techniques, underpinning its vital presence in the cardiovascular treatment sector. Its products are essential in supporting cardiac surgeons and healthcare professionals in utilizing life-saving technologies during complex medical procedures. Artivion Inc. serves a global market, impacting numerous aspects of healthcare by enabling the treatment of complex heart conditions and elevating surgical efficiency and efficacy. Headquartered in the United States, the company continues its commitment to innovation and quality in medical technology, playing a crucial role in advancing health outcomes and directly contributing to the fields of cardiovascular surgery and transplant medicine.
“Artivion Inc.'s ROE is 2.7%. Explore profitability and growth together.”
Ask for details →Artivion Inc. (ticker: AORT) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 1,600 employees.
The current price is $25.41 with a P/E ratio of -x and P/B of -x.
ROE is 2.70% and operating margin is 6.06%. Annual revenue is $441M.